GlassScriptPhysician profile
Jeffrey Coury
NPI 1740312487
$4,494.61
in general payments reported to CMS, 2019-2025
15 companies · $908 in 2025
The $908 reported for 2025 was more than what 84% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $459 · 2020: $502 · 2021: $293 · 2022: $1,426 · 2023: $199 · 2024: $707 · 2025: $908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,814.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $839.91 | 2022 | |
| Genzyme Corporation | $765.49 | 2019-2025 | |
| Acclarent, INC | $724.17 | 2019-2022 | |
| Integra Lifesciences Corporation | $645.10 | 2024-2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Optinose US, INC. | $444.84 | 2019-2025 | |
| Oticon Medical, LLC | $249.03 | 2019-2020 | |
| Aerin Medical INC. | $208.86 | 2020-2025 | |
| Intersect Ent, INC. | $153.18 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $131.63 | 2019-2024 | Dupixent |
| Glaxosmithkline, LLC. | $98.11 | 2025 | Nucala |
| Medtronic, INC. | $78.66 | 2022-2025 | Propel, Nuvent |
| Stryker Corporation | $63.87 | 2019-2025 | 1788 |
| Merck Sharp & Dohme LLC | $55.16 | 2025 | Keytruda |
| Inspire Medical Systems, INC. | $19.91 | 2025 | Inspire |
| Paratek Pharmaceuticals, INC. | $16.69 | 2025 | Xhance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Coury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.